Sandostatin LAR depot 30 MG KTS
Ended Awarded
- Contract number
- SPE2DR26F9AG8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,219
Award facts
- Contract value 100% obligated
- $68,219.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $68,219.40 by the Defense Logistics Agency (DLA) on November 5, 2025, with an ultimate completion date of November 6, 2025. The delivery order, issued under a firm fixed-price contract structure with no set-aside designation, pertains to Sandostatin LAR Depot 30 mg kits—a specialty pharmaceutical product used in medical treatment. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026.
The contract exemplifies AmerisourceBergen's critical role in federal pharmaceutical procurement, particularly for military and veteran healthcare systems. The company's comprehensive IDC with DLA serves as a global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems. AmerisourceBergen's consistent receipt of competitively awarded, non-set-aside delivery orders demonstrates its capability to meet federal medical supply requirements while supporting the DLA's broader mission to provision military medical programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F9AG8?
SPE2DR26F9AG8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26F9AG8 worth?
The government has obligated $68,219 on SPE2DR26F9AG8.
Is contract SPE2DR26F9AG8 an order under another contract?
Yes. SPE2DR26F9AG8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AG8 competed?
The extent of competition for SPE2DR26F9AG8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award